Clinical Trial Update: Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ravulizumab for pregnancies with severe hypertensive disorders, such as preeclampsia, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Ravulizumab (ravulizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Preeclampsia | Phase 2 | Status: RECRUITING